Zdravka Medarova
Co-Founder & Chief Technology Officer TransCode Therapeutics
Seminars
Wednesday 28th January 2026
Testing Novel Drug Design Engines for Cancer for Improved Efficacy and Toxicity Mitigation
2:30 pm
- Exploring the challenges of delivering RNAi to cancer
- Evaluating potential strategies to enable the development of RNAi-based drugs
- Presenting examples of emerging RNAi-based therapeutics for cancer
